Euro Trust (FXE) 111.29 $FXE BMY, HON, PG, UL: Jim

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Euro Trust (FXE) 111.29 $FXE

BMY, HON, PG, UL: Jim Cramer's Views
at The Street - Mon Sep 21, 12:00AM CDT
Jim Cramer shares his views on miserable output and the dollar. Bristol-Myers Squibb, Honeywell, Procter & Gamble and Unilever are among the stocks discussed here.
GE: 28.07 (+0.04), PHG: 25.62 (+0.36), HON: 101.16 (+0.09), UL: 42.67 (-0.23), PG: 74.48 (+0.08), FXE: 111.29 (+0.77), BMY: 61.44 (+0.93), PEP: 99.47 (+0.50)

'Fast Money' Recap: After Fed's Inaction, Time to Buy Gold, U.S. Dollar
at The Street - Sat Sep 19, 4:00AM CDT
The trading panel discussed what sectors to buy and sell now that interest rates are staying low, and whether Netflix should be on your list.
NFLX: 113.33 (-1.60), SPY: 201.33 (+0.12), FXE: 111.29 (+0.77), GDX: 16.26 (+0.85), UUP: 24.72 (-0.12)

The Fed Decision Will Boost U.S. Companies' Earnings
at The Street - Fri Sep 18, 4:48AM CDT
Janet Yellen has just given the gift of a weaker dollar.
GE: 28.07 (+0.04), PHG: 25.62 (+0.36), UL: 42.67 (-0.23), PG: 74.48 (+0.08), FXE: 111.29 (+0.77), PEP: 99.47 (+0.50)

Euro Could Get Crushed; Stronger Dollar Still Looming
at The Street - Fri Sep 11, 9:00AM CDT
The On-Balance-Volume line on the Currency Shares Euro Trust ETF is pointed lower, suggesting further weakness ahead.
FXE: 111.29 (+0.77)

BUYINS.NET: CHSP, MITL, FXE, TDG, ROX, IAT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 08, 7:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Chesapeake Lodging Trust (NYSE:CHSP), MITEL NETWORKS CORP (NASDAQ:MITL), CurrencyShares Euro Trust (NYSE:FXE), TRANSDIGM GROUP INCORPORATED (NYSE:TDG), Canstar Resources Inc (NYSE:ROX), Ishares Dow Jones US Regional Banks Fund (NYSE:IAT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CHSP: 28.84 (-0.02), TDG: 220.31 (+0.69), ROX: 1.33 (-0.02), IAT: 34.26 (-0.38), FXE: 111.29 (+0.77), MITL: 8.17 (-0.01)

Top ETF Stories of August
Zacks Equity Research - Zacks Investment Research - Mon Aug 31, 10:15AM CDT
Inside the top financial stories of August and the impact on related ETFs.
AAXJ: 57.13 (+0.20), CNY: 42.50 (unch), USO: 15.99 (-0.05), FXY: 80.66 (-0.19), TLT: 122.28 (+0.32), UUP: 24.72 (-0.12), EEM: 35.94 (+0.13), SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), GLD: 110.87 (+1.73), CYB: 25.04 (+0.04), DIA: 170.76 (+0.39), FXE: 111.29 (+0.77)

Euro & Long-term U.S. Treasury: Two ETFs Trading with Outsized Volume
Zacks Equity Research - ZACKS - Wed Aug 26, 12:30AM CDT
FXE and EDV saw massive trading volumes in Tuesday trading session.
SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), EDV: 117.10 (+0.21), DIA: 170.76 (+0.39), FXE: 111.29 (+0.77)

Forget Dollar, Look at These European Currency ETFs
Zacks Equity Research - Zacks Investment Research - Tue Aug 25, 1:40PM CDT
Thanks to the rise of risk-off trade sentiments and reduced Fed tightening worries, these currency ETFs gained considerably lately while the greenback slumped.
FXE: 111.29 (+0.77), FXF: 100.66 (+0.51), UUP: 24.72 (-0.12), FXS: 120.17 (+0.70)

Why We're on the Road to a Deeper Pulverizing in the Market
at The Street - Mon Aug 24, 7:00AM CDT
Here are four reasons stocks were down as much as they were Friday. And here's the road we're on.
TJX: 72.78 (+0.55), DE: 79.87 (-1.04), AGCO: 47.01 (-0.57), FXE: 111.29 (+0.77), FL: 71.04 (-0.26), HPQ: 29.30 (+0.12), ROST: 49.04 (+0.02), CRM: 75.25 (+0.16)

We're on 2 Roads to a Deeper Pulverizing, Even Though Friday Should've Been Better
at The Street - Sun Aug 23, 5:45PM CDT
Here are four reasons Friday was down as much as it was.
TJX: 72.78 (+0.55), AGCO: 47.01 (-0.57), DE: 79.87 (-1.04), FXE: 111.29 (+0.77), FL: 71.04 (-0.26), HPQ: 29.30 (+0.12), ROST: 49.04 (+0.02)

3 Factors Can Kill This Rally
at The Street - Mon Aug 10, 6:02PM CDT
People get so euphoric after a day like today, but it's been a sucker's play to do so.
GOOGL: 671.24 (+4.24), FXE: 111.29 (+0.77)

Cramer's Looking to Greece, China for the Market's Direction
at The Street - Thu Jul 09, 3:15PM CDT
Jim Cramer says a resolution in Greece would boost stocks and the U.S. stock market shouldn't be tied to China.
BIDU: 144.22 (+2.96), FXE: 111.29 (+0.77)

What Will It Take to Boost Markets Back in the Green? Cramer Explains
at The Street - Wed Jul 08, 3:08PM CDT
Halfway through an ugly week, the question on investors' minds is, what needs to happen to get the market headed in the right direction? Jim Cramer has a long checklist.
RDUS: 57.80 (-3.30), DBD: 33.24 (+0.34), AGN: 274.84 (-1.32), VIPS: 18.17 (-0.46), ALDR: 28.80 (-0.56), AA: 10.26 (-0.75), WBA: 85.37 (+1.09), RCPT: 231.96 (-0.03), DIS: 105.56 (+0.95), FXE: 111.29 (+0.77), AAPL: 112.12 (+2.62)

Amid All the Gloom, a Ray of Sunshine (It's Fed-Related)
at The Street - Wed Jul 08, 3:07PM CDT
Use downturns to buy the stocks of high-quality companies that you like.
HD: 121.33 (+0.27), KR: 38.03 (+0.03), CLX: 120.52 (+0.34), KMB: 114.73 (+0.93), COST: 153.97 (+2.31), DIS: 105.56 (+0.95), FXE: 111.29 (+0.77), PG: 74.48 (+0.08), PEP: 99.47 (+0.50), UAL: 55.71 (+3.45)

Large, Powerful Forces Are at Work in This Market
at The Street - Wed Jul 08, 4:15AM CDT
Why did the consumer packaged goods stocks all go up at once?
KO: 42.02 (+0.04), KR: 38.03 (+0.03), CLX: 120.52 (+0.34), KMB: 114.73 (+0.93), FXE: 111.29 (+0.77), PG: 74.48 (+0.08), PEP: 99.47 (+0.50)

Pay Attention to What Matters: The Dollar
at The Street - Tue Jul 07, 7:31AM CDT
Forget Greece. The stronger the dollar, the worse the earnings -- starting tomorrow.
FXE: 111.29 (+0.77)

When Friedman And Krugman Agree
Scott Sumner - Seeking Alpha - Tue Jul 07, 1:53AM CDT
Lots of people now understand that the euro was a very serious mistake. But most still don't understand just how badly the project was botched. Let's start with the obvious. If you are going to launch a grand experiment in monetary policy (like NGDP...
ULE: 17.11 (+0.25), GREK: 10.31 (-0.06), URR: 18.62 (+0.22), EU: 20.54 (-0.08), FXE: 111.29 (+0.77), EUO: 23.60 (-0.35), EUFX: 42.08 (-0.26), ERO: 42.14 (unch), DRR: 54.80 (-0.65)

Jobs Take Backseat To Greece's Austerity Vote
Kristina Hooper - Seeking Alpha - Tue Jul 07, 12:52AM CDT
The US labor market took a step back in June but the long-term trend toward healthier job growth remains intact. However, for now, the markets are preoccupied with the possibility of Greece exiting the euro zone on the heels of its "no"...
ULE: 17.11 (+0.25), GREK: 10.31 (-0.06), URR: 18.62 (+0.22), EU: 20.54 (-0.08), FXE: 111.29 (+0.77), EUO: 23.60 (-0.35), EUFX: 42.08 (-0.26), ERO: 42.14 (unch), DRR: 54.80 (-0.65)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 25

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 191

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Beijing's EV Export Rules Impact NIO and Li Auto Stocks

Updated Category News Views 298

Beijing Implements Stricter EV Export Regulations Affecting Stocks Recently, Chinese electric vehicle (EV) stocks NIO (NYSE: NIO) and Li Auto (NASDAQ: LI) have experienced a notable decline following announcements regarding new regulations by Beijing aimed at tightening the export of EVs. New Export Permit Requirements Effective from January 1, the Ministry of Commerce in...

Continue Reading
OceanaGold Set to Announce Q2 2025 Financial Results Soon

Updated Category News Views 122

Upcoming Financial Results from OceanaGold OceanaGold Corporation (TSX: OGC, OTCQX: OCAND) is gearing up to release its operational and financial results for the second quarter of 2025. This detailed announcement will take place after the market close, and it’s expected to shed light on the company's recent performance and highlight future prospects. Conference Call...

Continue Reading
India's July Industrial Growth Surpasses Expectations by 0.1%

Updated Category News Views 121

India's Industrial Output Shows Promising Growth in July Recent government data reveals that India's industrial output rose by a noteworthy 4.8% year-on-year in July. This figure has drawn attention since it slightly exceeds economists' forecast of 4.7% for the same month. These growing numbers reflect a resilient manufacturing sector that is steadily recovering....

Continue Reading
VideoAmp Extends Partnership with Paramount Global for Measurement

Updated Category News Views 180

VideoAmp and Paramount Global Strengthen Their Collaboration VideoAmp, a pioneering media measurement company, has recently announced the continuation of its long-term collaboration with Paramount Global. This partnership reflects a commitment to evolving the advertising landscape with precise audience insights. Comprehensive Audience Measurement This renewal provides...

Continue Reading
Empire State Realty Trust Delivers Strong Q3 Performance and Guidance

Updated Category News Views 53

Empire State Realty Trust Shows Remarkable Q3 Financial Results Empire State Realty Trust (NYSE: ESRT) demonstrated impressive financial outcomes in its most recent earnings call for the third quarter of 2024, surpassing analyst expectations significantly. The real estate investment trust revealed a Funds From Operations (FFO) totaling $69 million, translating to $0.26...

Continue Reading